Internal Medicine, Endocrinology, Diabetes, & Metabolism · Medina, OH
NPI
1417935263
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4087 Medina Rd, Suite 400
Medina, OH, 44256
Phone (330) 725-3713
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
690 services
Medicare patients, 2024
279
Average age 74
Drug cost, 2024
$1.2M
4,771 prescriptions
Company payments, 2025
$416
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard K Shewbridge was code 99214 (office e&m - established), 310 times for 233 patients. In total Richard K Shewbridge billed 690 services in 13 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-06-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 310 | 233 | $62.51 | $19K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 289 | 230 | $12.17 | $3,518 |
| 99232 Hospital E&M - Subsequent | Facility | 42 | 22 | $58.15 | $2,442 |
| 99233 Hospital E&M - Subsequent | Facility | 16 | 15 | $83.76 | $1,340 |
By year: 2022 $26K for 414 services; 2023 $26K for 418 services; 2024 $29K for 690 services.
Medicare prescription drug claims, 2024
In 2024, the drug Richard K Shewbridge prescribed most often to Medicare patients was Levothyroxine Sodium, with 737 prescriptions and refills. In total Richard K Shewbridge wrote 4,771 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 737 | 1,961 | 195 | $7,618 |
| Metformin Hcl Er Metformin Hcl | 202 | 533 | 66 | $2,604 |
| Glimepiride Generic | 177 | 493 | 48 | $1,350 |
| Alendronate Sodium Generic | 162 | 443 | 55 | $1,620 |
| Metformin Hcl Generic | 162 | 452 | 52 | $1,427 |
| Atorvastatin Calcium Generic | 154 | 414 | 44 | $1,894 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 152 | 425 | 58 | $26K |
| Jardiance Empagliflozin | 111 | 258 | 32 | $143K |
| Amlodipine Besylate Generic | 106 | 271 | 26 | $346 |
| Synthroid Levothyroxine Sodium | 106 | 316 | 37 | $6,155 |
| Lisinopril Generic | 101 | 275 | 29 | $466 |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 91 | 208 | 28 | $43K |
| Ozempic Semaglutide | 89 | 127 | 19 | $120K |
| Rosuvastatin Calcium Generic | 87 | 231 | 28 | $964 |
| Losartan Potassium Generic | 81 | 209 | 24 | $779 |
Brand drugs: 1,546 claims; generic drugs: 2,982 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard K Shewbridge $416 ($416 in general payments such as food, travel and fees) from 7 companies. The largest payer was Ascendis Pharma Endocrinology Inc with $107.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.